| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0304-3835(00)00649-2 |
| P8608 | Fatcat ID | release_aqnironixrgk7h32cm575bx3bu |
| P698 | PubMed publication ID | 11164187 |
| P2093 | author name string | F J Rauscher | |
| K Ayyanathan | |||
| W J Fredericks | |||
| P2860 | cites work | KAP-1 corepressor protein interacts and colocalizes with heterochromatic and euchromatic HP1 proteins: a potential role for Krüppel-associated box-zinc finger proteins in heterochromatin-mediated gene silencing. | Q22010040 |
| Reconstitution of the KRAB-KAP-1 repressor complex: a model system for defining the molecular anatomy of RING-B box-coiled-coil domain-mediated protein-protein interactions | Q22011176 | ||
| Transcriptional modulation of the anti-apoptotic protein BCL-XL by the paired box transcription factors PAX3 and PAX3/FKHR | Q22254411 | ||
| The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3 | Q24313754 | ||
| KAP-1, a novel corepressor for the highly conserved KRAB repression domain | Q24317676 | ||
| Repression of transcriptional activity by heterologous KRAB domains present in zinc finger proteins | Q24324594 | ||
| Molecular determinants for targeting heterochromatin protein 1-mediated gene silencing: direct chromoshadow domain-KAP-1 corepressor interaction is essential | Q24551928 | ||
| Krüppel-associated boxes are potent transcriptional repression domains | Q24563259 | ||
| Toward controlling gene expression at will: specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks | Q24645403 | ||
| Positive and negative regulation of endogenous genes by designed transcription factors | Q24649843 | ||
| Design of polydactyl zinc-finger proteins for unique addressing within complex genomes | Q24676208 | ||
| Identification of in vivo DNA targets of chromatin proteins using tethered dam methyltransferase | Q28140783 | ||
| Zinc finger peptides for the regulation of gene expression | Q28146002 | ||
| Regulation of the MDR1 gene by transcriptional repressors selected using peptide combinatorial libraries | Q30881546 | ||
| RNA polymerase II as a control panel for multiple coactivator complexes | Q33632354 | ||
| A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites | Q33706825 | ||
| Repression: targeting the heart of the matter | Q33789555 | ||
| An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene | Q33964561 | ||
| Modular structure of transcription factors: implications for gene regulation | Q34110705 | ||
| A eukaryotic transcriptional activator bearing the DNA specificity of a prokaryotic repressor | Q34194676 | ||
| Pax genes and organogenesis. | Q34439185 | ||
| Groucho acts as a corepressor for a subset of negative regulators, including Hairy and Engrailed | Q35196294 | ||
| Analysis of mechanisms that determine dominant negative estrogen receptor effectiveness | Q38287686 | ||
| A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins | Q38295120 | ||
| The Gfi-1 proto-oncoprotein contains a novel transcriptional repressor domain, SNAG, and inhibits G1 arrest induced by interleukin-2 withdrawal | Q40020247 | ||
| Inhibition of human hematopoietic tumor formation by targeting a repressor Myb-KRAB to DNA. | Q40870142 | ||
| Exogenous cdk4 overcomes reduced cdk4 RNA and inhibition of G1 progression in hematopoietic cells expressing a dominant-negative CBF - a model for overcoming inhibition of proliferation by CBF oncoproteins | Q40874612 | ||
| Understanding gene and allele function with two-hybrid methods. | Q40909651 | ||
| A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells | Q40912005 | ||
| Transiently transfected and stably integrated HIV-1 LTR responds differentially to the silencing activity of the Krüppel-associated box (KRAB) transcriptional repressor domain | Q40935372 | ||
| Repression and activation by multiprotein complexes that alter chromatin structure | Q40975338 | ||
| Inhibition of Tat-mediated transactivation and HIV replication with Tat mutant and repressor domain fusion proteins | Q40995031 | ||
| Retinoblastoma protein tethered to promoter DNA represses TBP-mediated transcription | Q41023470 | ||
| Gene fusions encoding chimaeric transcription factors in solid tumours | Q41025087 | ||
| Active repression of transcription by the engrailed homeodomain protein | Q41080980 | ||
| A dominant interfering Myb mutant causes apoptosis in T cells | Q41153561 | ||
| Active repression mechanisms of eukaryotic transcription repressors | Q41223932 | ||
| Progress in transcriptionally targeted and regulatable vectors for genetic therapy | Q41464703 | ||
| Transcriptional repression mediated by the WT1 Wilms tumor gene product | Q41661461 | ||
| Estrogen receptor-KRAB chimeras are potent ligand-dependent repressors of estrogen-regulated gene expression | Q42487378 | ||
| Suppression of gene expression by tethering KRAB domain to promoter of ER target genes | Q45859464 | ||
| Tissue-selective expression of dominant-negative proteins for the regulation of vascular smooth muscle cell proliferation | Q45861589 | ||
| Zinc finger proteins as designer transcription factors. | Q45866068 | ||
| Dominant interfering alleles define a role for c-Myb in T-cell development. | Q52217579 | ||
| Chromosomal translocations in human cancer. | Q52512616 | ||
| Negative regulation of the forkhead transcription factor FKHR by Akt. | Q52535267 | ||
| The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts | Q57756648 | ||
| Chromosomal abnormalities and tumor development: from genes to therapeutic mechanisms | Q77745393 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | S23-S32 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Cancer Letters | Q326372 |
| P1476 | title | Regulating the neoplastic phenotype using engineered transcriptional repressors | |
| P478 | volume | 162 Suppl |
| Q28305509 | Cell-type-specific regulation of distinct sets of gene targets by Pax3 and Pax3/FKHR |
| Q35847829 | Childhood rhabdomyosarcoma: recent advances and prospective views |
| Q34456861 | Chromosomal translocations in sarcomas: prospects for therapy |
| Q35057457 | Ewing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities |
| Q35198613 | Experimental approaches to treatment of soft tissue sarcoma |
| Q73408826 | International symposium on biology of cancer prevention and treatment |
| Q37180948 | Molecular approaches to sarcoma therapy |
| Q36250783 | Molecular profiling of childhood cancer: Biomarkers and novel therapies |
| Q34990652 | New insights in the transcriptional activity and coregulator molecules in the arterial wall |
Search more.